Literature DB >> 6622052

The needs and unique problems facing spinal cord injured persons after limb amputation.

A Ohry, M Heim, T V Steinbach, R Rozin.   

Abstract

Among hundreds of spinal cord injured patients (SCIP) who have been rehabilitated in the Sir Ludwig Guttmann Spinal Cord Injury Unit at the Sheba Medical Centre, Tel Hashomer; we only found six patients who had lost one or more limbs (upper or lower limbs). Although many plastic and orthopaedic surgeons regard paralytic limbs as useless appendages, we cannot agree with this erroneous viewpoint and we find that the clinical and psychological effects of the absence of limb(s) are tremendous. The six case reports are given together with a brief review of the relevant literature.

Entities:  

Mesh:

Year:  1983        PMID: 6622052     DOI: 10.1038/sc.1983.41

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  5 in total

1.  Paraplegia and transtibial amputation: successful ambulation after dual disability: a retrospective case report.

Authors:  Thangavelu Senthilvelkumar; Bobeena R Chandy
Journal:  Spinal Cord Ser Cases       Date:  2017-02-02

2.  Integral multidisciplinary approach in a patient with chronic complete spinal cord injury and hip disarticulation.

Authors:  J Quinzaños-Fresnedo; G Rodríguez-Reyes; C Mendoza-Cosío; R Pérez-Zavala; E A Márquez-Guitérrez; S Hernández-Sandoval
Journal:  Spinal Cord Ser Cases       Date:  2015-10-08

3.  Limb loss in individuals with chronic spinal cord injury.

Authors:  Jelena Svircev; Debbie Tan; Ashley Garrison; Brent Pennelly; Stephen P Burns
Journal:  J Spinal Cord Med       Date:  2020-08-18       Impact factor: 2.040

4.  Rehabilitation for patients with paraplegia and lower extremity amputation.

Authors:  Fangyong Wang; Yi Hong
Journal:  J Phys Ther Sci       Date:  2015-10-30

5.  Spinal cord injury due to fall from electricity poles after electrocution.

Authors:  Amir Zeb; Aatik Arsh; Sher Bahadur; Syed Muhammad Ilyas
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.